retatrutide mechanism clinical trial retatrutide 💉 A triple-action once-weekly injection can significantly lower blood sugar and body weight in people with type 2 diabetes, a new phase 3 shows. is part of an emerging generation Retatrutide (RETA) is one of

Our expert providers

GLP-1 Patent Expiry: The Next Big Pharma Race Has Begun GLP-1 agonists like semaglutide, tirzepatide, and liraglutide have reshaped the global diabetes and obesity market

Ensuring equitable access and strengthening health systems will be essential to prevent widening health disparities.AgendaCo-chairsDr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMAModeratorDr Gaya Manori Gamhewage, Director, Department of Communication, WHOWelcomingDr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMAPresentation:WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adultsDr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr

Pura Collagen has launched GLPure+ and Pura Digest, expanding its product line to address the GLP-1 trend and digestive health

With the recent announcement that the shortage of Ozempic and Wegovy is officially over, the FDA has declared that compounding pharmacies must stop producing and selling compounded semaglutide by May 22, 2025

Discover how to eat for optimal results while taking GLP-1 medications like Wegovy or Saxenda